Publications by authors named "C K Janniger"

Key Clinical Message: High-dose intravenous immunoglobulin exhibits great potential in the treatment of Netherton syndrome.

Abstract: Netherton syndrome (NS) is a rare autosomal recessive genodermatosis (OMIM #256500) characterized by superficial scaling, atopic manifestations, and multisystemic complications. It is caused by loss-of-function mutations in the SPINK5 gene, which encode a key kallikrein protease inhibitor.

View Article and Find Full Text PDF
Article Synopsis
  • Autoeczematization, also known as an id reaction, is an eczema-like reaction that happens when skin antigens are released after an initial skin irritation, causing eczema to appear in other areas.
  • This condition is often linked to issues like stasis dermatitis (poor blood flow) or tinea pedis (athlete's foot) but can be triggered by various skin disorders.
  • Researchers believe that T cells react to damaged skin cells, leading to this widespread eczema, highlighting the need for more studies using modern technology to better understand the process.
View Article and Find Full Text PDF

Background: Traction alopecia is common and preventable but frequently overlooked disorder.

Objective: To evaluate patients with traction alopecia.

Patients And Methods: This study was conducted at the Dermatology Center, Medical City, Baghdad, Iraq, during the period from November 2005 to October 2019.

View Article and Find Full Text PDF

Female pattern hair loss is a common form of hair loss in women that increases in incidence with age. The etiology is unknown with numerous factors identified that influence its onset. Female pattern hair loss may be viewed as a marker for an increased risk of cardiovascular and metabolic disease.

View Article and Find Full Text PDF

A severe cutaneous drug reaction resembling acute generalized exanthematous pustulosis resulting from ingestion of hydroxychloroquine has been documented. It is distinguishable by its longer incubation period, more varied morphology with initially urticarial and later targetoid and arcuate plaques, recalcitrance to therapy and longer duration. Given the anticipated surge in the use of hydroxychloroquine due to its reported benefits in those with coronavirus disease 2019, specific recognition of this entity is pivotal.

View Article and Find Full Text PDF